The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
Not yet recruiting · NCT07287228 · Registry updated 2025-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia | Bone Marrow Failure Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-12-17 | NCT07287228 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hosptial, Chinese Academy of Medical Science and Peking Union Medical School | Tianjin | China | 1 |